DNASE1 and neoplasm: Of note, LPS-induced NET model mice treated with the p38 MAPK pathway inhibitor exhibited lower tumour volumes than those treated with DNase I, suggesting that not only NET-DNA but also other components of NETs have the ability to accelerate tumour growth.